Content continues after advertisement

Anaphylactic Hemoperitoneum in Dogs

Michelle Goodnight, DVM, MS, DACVECC, Gwinnett Technical College, Lawrenceville, Georgia

Emergency Medicine & Critical Care

|November/December 2021

Sign in to Print/View PDF

In the Literature

Hnatusko AL, Gicking JC, Lisciandro GR. Anaphylaxis-related hemoperitoneum in 11 dogs. J Vet Emerg Crit Care (San Antonio). 2021;31(1):80-85.


Common signs of anaphylaxis in dogs include hemorrhagic gastroenteritis, hepatic congestion, gallbladder wall edema, increased liver enzyme activity, hemoconcentration, cutaneous manifestations (eg, hives), and, in severe cases, acute cardiovascular collapse and death. 

This retrospective case series describes hemoperitoneum, a less common complication of anaphylaxis. Coagulopathy of anaphylaxis is rare, and patients are presented with nontraumatic hemoperitoneum. This multifactorial phenomenon is poorly understood and has only been described twice in veterinary and once in human medicine literature.1-3 

Eleven previously healthy dogs with acute onset of clinical signs consistent with anaphylaxis and with confirmed hemoperitoneum were presented after collapse or acute weakness. No dogs had cutaneous manifestations or pleural, pericardial, or pulmonary fluid accumulation. Most dogs exhibited concurrent GI signs, 4 dogs had hypoglycemia, and 5 dogs had coagulopathy that was confirmed by blood work.

Treatment varied among patients and included epinephrine, fluid therapy, diphenhydramine, famotidine, and glucocorticoids. Eight dogs received fresh frozen plasma, and 2 dogs required RBC transfusion. 

Anaphylactic hemoperitoneum should be considered in cases of nontraumatic hemoperitoneum with no clear cause and concurrent clinical signs of anaphylaxis (eg, distributive shock, elevated ALP, gallbladder halo sign on ultrasound indicative of gallbladder wall edema). 

The need for fresh frozen plasma and RBC transfusion in this case series suggests that early identification of anaphylactic coagulopathy and hemoperitoneum can improve treatment decisions and outcome.


Key pearls to put into practice:


Approximately 20% of patients presented with anaphylaxis do not show dermal signs4; therefore, lack of dermal manifestations should not exclude anaphylaxis as a differential diagnosis in patients with other clinical signs of anaphylaxis.


Nontraumatic hemoperitoneum is a documented complication of anaphylaxis, which should be a differential diagnosis when hemoperitoneum is present along with gallbladder halo sign, elevated ALP, and GI signs.


Medical management of anaphylactic hemoperitoneum consists of epinephrine and fluid therapy. Surgery is contraindicated. Addition of H1-receptor antagonists (eg, diphenhydramine), H2-receptor antagonists (eg, famotidine), glucocorticoids, and blood products should be based on individual patient parameters.


For global readers, a calculator to convert laboratory values, dosages, and other measurements to SI units can be found here.

All Clinician's Brief content is reviewed for accuracy at the time of publication. Previously published content may not reflect recent developments in research and practice.

Material from Clinician's Brief may not be reproduced, distributed, or used in whole or in part without prior permission of Educational Concepts, LLC. For questions or inquiries please contact us.


Clinician's Brief:
The Podcast

Listen as host Alyssa Watson, DVM, talks with the authors of your favorite Clinician’s Brief articles. Dig deeper and explore the conversations behind the content here.
Clinician's Brief provides relevant diagnostic and treatment information for small animal practitioners. It has been ranked the #1 most essential publication by small animal veterinarians for 9 years.*

*2007-2017 PERQ and Essential Media Studies

© Educational Concepts, L.L.C. dba Brief Media ™ All Rights Reserved. Privacy Policy (Updated 05/08/2018) Acceptable Use Policy (Updated 11/22/2021)